Oral vs. Vaginal Medicine for Miscarriage Management
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study compares two ways of taking medicine (by mouth or vaginal insertion) to safely manage a miscarriage that was discovered on ultrasound between 8–16 weeks of pregnancy. The goal is to see which method works better and causes fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You've had fewer than 5 previous pregnancies (including this one)
- Ultrasound confirms the pregnancy has stopped developing with no fetal heartbeat, and you are 8–16 weeks along
- You have mild to moderate lower abdominal cramping
- Your cervix has not started to open or dilate
- You do not have signs of infection, excessive bleeding, or very high blood pressure (≥160/90)
- You do not have a history of asthma, heart disease, or stroke
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different treatment methods for early missed abortion (when a pregnancy ends but the tissue doesn't pass on its own) to see which works best in real-world settings. It may help you and your doctor choose the safest and most effective option.
This trial tests whether giving oxytocin during a dilation and curettage (D&C) procedure for a first-trimester miscarriage helps reduce bleeding and other complications. Oxytocin is a medicine that helps the uterus contract, which may make the procedure safer and more effective.
This trial tests two different medicines (Mifepristone vs Misoprostol) to see which works better for ending a pregnancy in the second trimester (12–16 weeks). It is for people who are pregnant with one baby and have no major health issues that could affect safety.
This trial compares two ways to treat a first-trimester miscarriage that needs surgery: one is done in a clinic using a handheld suction device, the other is done in an operating room using electric suction. The study looks at costs and how well each method works.
This trial tests whether taking an aromatase inhibitor (letrozole) before misoprostol helps complete a miscarriage more effectively. It may offer a treatment option for people with a missed or early pregnancy loss.
This study compares two medications—letrozole plus misoprostol versus misoprostol alone—to see which is more effective for ending a pregnancy in the second trimester (14–20 weeks) after the fetus has stopped developing. The goal is to find a safer, more comfortable method for women who need this procedure.
Hear when a new Missed Abortion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.